NPB and nasopharyngeal carcinoma: It was presumptively identified in control and carrier (≤0.5 ng/mL), NPC (1.5–6.5 ng/mL), NPB (2–6.5 ng/mL) and LALD (1–5.5 ng/mL) plasma (Fig. 5E, see Fig. 5D in Ref.